Harmony Biosciences Holdings (HRMY) Other financing activities (2019 - 2021)

Harmony Biosciences Holdings has disclosed Other financing activities across 3 years of filings, most recently posting $8.9 million for Q4 2021.

• Other financing activities for Q4 2021 came in at $8.9 million, up 252.96% year-over-year; the trailing twelve-month figure through Dec 2023 was $3.1 million (changed N/A YoY), and the FY2023 annual result was $3.0 million, changed N/A from the prior year.
• Other financing activities came in at $8.9 million for Q4 2021 at Harmony Biosciences Holdings, up from -$5.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $8.9 million in Q4 2021 to a low of -$5.8 million in Q4 2020.
• The 3-year median for Other financing activities is $875000.0 (2019), against an average of $2.0 million.
• Across the five-year window, Other financing activities plunged 761.37% in 2020 and surged 252.96% in 2021, its largest moves.
• Harmony Biosciences Holdings' Other financing activities stood at $875000.0 in 2019, then slumped by 761.37% to -$5.8 million in 2020, then soared by 252.96% to $8.9 million in 2021.
• The last three Other financing activities figures came in at $8.9 million (Q4 2021), -$5.8 million (Q4 2020), and $17000.0 (Q3 2020), per Business Quant data.